Postdoctoral Researcher
Department of Microbiology, Tumor and Cell Biology
Karolinska Institutet, Sweden

I am a postdoctoral researcher in the p53 group led by Professor Sir David Lane. 
My research focuses on tackling cancer resistance to therapy in two ways: 1) developing imaging methods that could aid in assessing response of individual tumors to therapy and 2) investigating how cell-cell communication in hypoxia contributes to treatment response. The ultimate goal of this work is to monitor response and resistance to conventional therapies for each cancer patient. 

I worked previously as a postdoctoral researcher at the University of Oxford (UK) with Professors Adrian Harris and Mike Partridge. There, I used interdisciplinary techniques (maths, physics, and biology) to measure how the tumor microenvironment influenced response to radiation treatment. My doctoral work was at the National Institutes of Health (USA) and at Karolinska Institutet (Sweden), where I evaluated the properties of imaging agents developed to measure drug resistance in neurological disorders and cancer.